Clinical Epigenetics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2097782, encodeId=5f98209e78283, content=我也来记录一下，2022.10.22投稿，2022.11.1状态变为1 reviewer accepted,目前感觉还挺快，希望一切顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743d5543690, createdName=孤松, createdTime=Tue Nov 01 10:55:10 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089070, encodeId=520620890e08b, content=太慢了 40天了还是Editor appointed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Mon Sep 19 18:52:38 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160854, encodeId=f255216085438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤 经验分享：230808投稿，230929显示1 Reviewer report received ，231003显示Editor appointed 。请问这是倒退了么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaf8384511, createdName=ms1000001061839733, createdTime=Wed Oct 04 09:06:39 CST 2023, time=2023-10-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136545, encodeId=a0702136545ef, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传 经验分享：投稿之后第二天就送了外审，一共四个审稿人。做的工作量稍大，偏基础，结合了bulk和单细胞数据分析。回修了三轮。编辑效率很高，很快处理文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230517/c94e696c22d346189f6cad2204d150c3.jpeg, type=image, width=487, height=721)], authenticateStatus=null, createdAvatar=, createdBy=57ae1631459, createdName=翌聲, createdTime=Wed May 17 13:15:10 CST 2023, time=2023-05-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192635, encodeId=c747219263537, content=准备投稿，看了大家评论，着急用文章，是不是不适合投这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/8f96f2c4e958d9381c71fd917902c6e7.jpg, createdBy=77442514173, createdName=职场小白, createdTime=Mon Mar 11 19:15:11 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=587139, encodeId=335e58e1396f, content=请问你从投到送审用了多久啊？我3.11显示editor assigned，今天都21号了，都没有变化，都10天了zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, beContent=zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoiaMS5CKu2YVJn7icDDrYG3ia3605r4AlgvkSuZlOrMic0LzfricZRAxwEMibf25ctcRIqEsdZJaicmnmbA/132, createdBy=72b22205339, createdName=cxw1008, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=)]

2022-11-01 孤松

我也来记录一下，2022.10.22投稿，2022.11.1状态变为1 reviewer accepted,目前感觉还挺快，希望一切顺利！

87 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097782, encodeId=5f98209e78283, content=我也来记录一下，2022.10.22投稿，2022.11.1状态变为1 reviewer accepted,目前感觉还挺快，希望一切顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743d5543690, createdName=孤松, createdTime=Tue Nov 01 10:55:10 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089070, encodeId=520620890e08b, content=太慢了 40天了还是Editor appointed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Mon Sep 19 18:52:38 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160854, encodeId=f255216085438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤 经验分享：230808投稿，230929显示1 Reviewer report received ，231003显示Editor appointed 。请问这是倒退了么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaf8384511, createdName=ms1000001061839733, createdTime=Wed Oct 04 09:06:39 CST 2023, time=2023-10-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136545, encodeId=a0702136545ef, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传 经验分享：投稿之后第二天就送了外审，一共四个审稿人。做的工作量稍大，偏基础，结合了bulk和单细胞数据分析。回修了三轮。编辑效率很高，很快处理文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230517/c94e696c22d346189f6cad2204d150c3.jpeg, type=image, width=487, height=721)], authenticateStatus=null, createdAvatar=, createdBy=57ae1631459, createdName=翌聲, createdTime=Wed May 17 13:15:10 CST 2023, time=2023-05-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192635, encodeId=c747219263537, content=准备投稿，看了大家评论，着急用文章，是不是不适合投这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/8f96f2c4e958d9381c71fd917902c6e7.jpg, createdBy=77442514173, createdName=职场小白, createdTime=Mon Mar 11 19:15:11 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=587139, encodeId=335e58e1396f, content=请问你从投到送审用了多久啊？我3.11显示editor assigned，今天都21号了，都没有变化，都10天了zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, beContent=zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoiaMS5CKu2YVJn7icDDrYG3ia3605r4AlgvkSuZlOrMic0LzfricZRAxwEMibf25ctcRIqEsdZJaicmnmbA/132, createdBy=72b22205339, createdName=cxw1008, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=)]

2022-02-21 1165291396

我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned
然后一个月状态纹丝不动，这真好慢啊，持续等待中

89 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097782, encodeId=5f98209e78283, content=我也来记录一下，2022.10.22投稿，2022.11.1状态变为1 reviewer accepted,目前感觉还挺快，希望一切顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743d5543690, createdName=孤松, createdTime=Tue Nov 01 10:55:10 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089070, encodeId=520620890e08b, content=太慢了 40天了还是Editor appointed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Mon Sep 19 18:52:38 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160854, encodeId=f255216085438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤 经验分享：230808投稿，230929显示1 Reviewer report received ，231003显示Editor appointed 。请问这是倒退了么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaf8384511, createdName=ms1000001061839733, createdTime=Wed Oct 04 09:06:39 CST 2023, time=2023-10-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136545, encodeId=a0702136545ef, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传 经验分享：投稿之后第二天就送了外审，一共四个审稿人。做的工作量稍大，偏基础，结合了bulk和单细胞数据分析。回修了三轮。编辑效率很高，很快处理文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230517/c94e696c22d346189f6cad2204d150c3.jpeg, type=image, width=487, height=721)], authenticateStatus=null, createdAvatar=, createdBy=57ae1631459, createdName=翌聲, createdTime=Wed May 17 13:15:10 CST 2023, time=2023-05-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192635, encodeId=c747219263537, content=准备投稿，看了大家评论，着急用文章，是不是不适合投这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/8f96f2c4e958d9381c71fd917902c6e7.jpg, createdBy=77442514173, createdName=职场小白, createdTime=Mon Mar 11 19:15:11 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=587139, encodeId=335e58e1396f, content=请问你从投到送审用了多久啊？我3.11显示editor assigned，今天都21号了，都没有变化，都10天了zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, beContent=zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoiaMS5CKu2YVJn7icDDrYG3ia3605r4AlgvkSuZlOrMic0LzfricZRAxwEMibf25ctcRIqEsdZJaicmnmbA/132, createdBy=72b22205339, createdName=cxw1008, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=)]

2021-09-06 Zero2326

请教一下，editor invited 代表什么进度？

69 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097782, encodeId=5f98209e78283, content=我也来记录一下，2022.10.22投稿，2022.11.1状态变为1 reviewer accepted,目前感觉还挺快，希望一切顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743d5543690, createdName=孤松, createdTime=Tue Nov 01 10:55:10 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089070, encodeId=520620890e08b, content=太慢了 40天了还是Editor appointed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Mon Sep 19 18:52:38 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160854, encodeId=f255216085438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤 经验分享：230808投稿，230929显示1 Reviewer report received ，231003显示Editor appointed 。请问这是倒退了么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaf8384511, createdName=ms1000001061839733, createdTime=Wed Oct 04 09:06:39 CST 2023, time=2023-10-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136545, encodeId=a0702136545ef, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传 经验分享：投稿之后第二天就送了外审，一共四个审稿人。做的工作量稍大，偏基础，结合了bulk和单细胞数据分析。回修了三轮。编辑效率很高，很快处理文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230517/c94e696c22d346189f6cad2204d150c3.jpeg, type=image, width=487, height=721)], authenticateStatus=null, createdAvatar=, createdBy=57ae1631459, createdName=翌聲, createdTime=Wed May 17 13:15:10 CST 2023, time=2023-05-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192635, encodeId=c747219263537, content=准备投稿，看了大家评论，着急用文章，是不是不适合投这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/8f96f2c4e958d9381c71fd917902c6e7.jpg, createdBy=77442514173, createdName=职场小白, createdTime=Mon Mar 11 19:15:11 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=587139, encodeId=335e58e1396f, content=请问你从投到送审用了多久啊？我3.11显示editor assigned，今天都21号了，都没有变化，都10天了zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, beContent=zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoiaMS5CKu2YVJn7icDDrYG3ia3605r4AlgvkSuZlOrMic0LzfricZRAxwEMibf25ctcRIqEsdZJaicmnmbA/132, createdBy=72b22205339, createdName=cxw1008, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=)]

2022-09-19 1e170646m17(暂无匿称)

太慢了 40天了还是Editor appointed

44 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097782, encodeId=5f98209e78283, content=我也来记录一下，2022.10.22投稿，2022.11.1状态变为1 reviewer accepted,目前感觉还挺快，希望一切顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743d5543690, createdName=孤松, createdTime=Tue Nov 01 10:55:10 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089070, encodeId=520620890e08b, content=太慢了 40天了还是Editor appointed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Mon Sep 19 18:52:38 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160854, encodeId=f255216085438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤 经验分享：230808投稿，230929显示1 Reviewer report received ，231003显示Editor appointed 。请问这是倒退了么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaf8384511, createdName=ms1000001061839733, createdTime=Wed Oct 04 09:06:39 CST 2023, time=2023-10-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136545, encodeId=a0702136545ef, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传 经验分享：投稿之后第二天就送了外审，一共四个审稿人。做的工作量稍大，偏基础，结合了bulk和单细胞数据分析。回修了三轮。编辑效率很高，很快处理文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230517/c94e696c22d346189f6cad2204d150c3.jpeg, type=image, width=487, height=721)], authenticateStatus=null, createdAvatar=, createdBy=57ae1631459, createdName=翌聲, createdTime=Wed May 17 13:15:10 CST 2023, time=2023-05-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192635, encodeId=c747219263537, content=准备投稿，看了大家评论，着急用文章，是不是不适合投这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/8f96f2c4e958d9381c71fd917902c6e7.jpg, createdBy=77442514173, createdName=职场小白, createdTime=Mon Mar 11 19:15:11 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=587139, encodeId=335e58e1396f, content=请问你从投到送审用了多久啊？我3.11显示editor assigned，今天都21号了，都没有变化，都10天了zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, beContent=zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoiaMS5CKu2YVJn7icDDrYG3ia3605r4AlgvkSuZlOrMic0LzfricZRAxwEMibf25ctcRIqEsdZJaicmnmbA/132, createdBy=72b22205339, createdName=cxw1008, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=)]

2023-10-04 ms1000001061839733 来自湖北省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：DNA甲基化;肿瘤
经验分享：230808投稿，230929显示1 Reviewer report received ，231003显示Editor appointed 。请问这是倒退了么？

43 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097782, encodeId=5f98209e78283, content=我也来记录一下，2022.10.22投稿，2022.11.1状态变为1 reviewer accepted,目前感觉还挺快，希望一切顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743d5543690, createdName=孤松, createdTime=Tue Nov 01 10:55:10 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089070, encodeId=520620890e08b, content=太慢了 40天了还是Editor appointed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Mon Sep 19 18:52:38 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160854, encodeId=f255216085438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤 经验分享：230808投稿，230929显示1 Reviewer report received ，231003显示Editor appointed 。请问这是倒退了么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaf8384511, createdName=ms1000001061839733, createdTime=Wed Oct 04 09:06:39 CST 2023, time=2023-10-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136545, encodeId=a0702136545ef, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传 经验分享：投稿之后第二天就送了外审，一共四个审稿人。做的工作量稍大，偏基础，结合了bulk和单细胞数据分析。回修了三轮。编辑效率很高，很快处理文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230517/c94e696c22d346189f6cad2204d150c3.jpeg, type=image, width=487, height=721)], authenticateStatus=null, createdAvatar=, createdBy=57ae1631459, createdName=翌聲, createdTime=Wed May 17 13:15:10 CST 2023, time=2023-05-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192635, encodeId=c747219263537, content=准备投稿，看了大家评论，着急用文章，是不是不适合投这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/8f96f2c4e958d9381c71fd917902c6e7.jpg, createdBy=77442514173, createdName=职场小白, createdTime=Mon Mar 11 19:15:11 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=587139, encodeId=335e58e1396f, content=请问你从投到送审用了多久啊？我3.11显示editor assigned，今天都21号了，都没有变化，都10天了zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, beContent=zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoiaMS5CKu2YVJn7icDDrYG3ia3605r4AlgvkSuZlOrMic0LzfricZRAxwEMibf25ctcRIqEsdZJaicmnmbA/132, createdBy=72b22205339, createdName=cxw1008, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=)]

2023-05-17 翌聲来自安徽省

精彩评论，需要您登录查看

46 2

[GetPortalCommentsPageByObjectIdResponse(id=2097782, encodeId=5f98209e78283, content=我也来记录一下，2022.10.22投稿，2022.11.1状态变为1 reviewer accepted,目前感觉还挺快，希望一切顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743d5543690, createdName=孤松, createdTime=Tue Nov 01 10:55:10 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089070, encodeId=520620890e08b, content=太慢了 40天了还是Editor appointed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Mon Sep 19 18:52:38 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160854, encodeId=f255216085438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤 经验分享：230808投稿，230929显示1 Reviewer report received ，231003显示Editor appointed 。请问这是倒退了么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaf8384511, createdName=ms1000001061839733, createdTime=Wed Oct 04 09:06:39 CST 2023, time=2023-10-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136545, encodeId=a0702136545ef, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传 经验分享：投稿之后第二天就送了外审，一共四个审稿人。做的工作量稍大，偏基础，结合了bulk和单细胞数据分析。回修了三轮。编辑效率很高，很快处理文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230517/c94e696c22d346189f6cad2204d150c3.jpeg, type=image, width=487, height=721)], authenticateStatus=null, createdAvatar=, createdBy=57ae1631459, createdName=翌聲, createdTime=Wed May 17 13:15:10 CST 2023, time=2023-05-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192635, encodeId=c747219263537, content=准备投稿，看了大家评论，着急用文章，是不是不适合投这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/8f96f2c4e958d9381c71fd917902c6e7.jpg, createdBy=77442514173, createdName=职场小白, createdTime=Mon Mar 11 19:15:11 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=587139, encodeId=335e58e1396f, content=请问你从投到送审用了多久啊？我3.11显示editor assigned，今天都21号了，都没有变化，都10天了zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, beContent=zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoiaMS5CKu2YVJn7icDDrYG3ia3605r4AlgvkSuZlOrMic0LzfricZRAxwEMibf25ctcRIqEsdZJaicmnmbA/132, createdBy=72b22205339, createdName=cxw1008, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=)]

2022-02-23 ms5000000155404164

审稿速度:6.0
经验分享：2021年投稿一篇，记录一下自己的投稿历程：
20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。
谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～

73 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097782, encodeId=5f98209e78283, content=我也来记录一下，2022.10.22投稿，2022.11.1状态变为1 reviewer accepted,目前感觉还挺快，希望一切顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743d5543690, createdName=孤松, createdTime=Tue Nov 01 10:55:10 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089070, encodeId=520620890e08b, content=太慢了 40天了还是Editor appointed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Mon Sep 19 18:52:38 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160854, encodeId=f255216085438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤 经验分享：230808投稿，230929显示1 Reviewer report received ，231003显示Editor appointed 。请问这是倒退了么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaf8384511, createdName=ms1000001061839733, createdTime=Wed Oct 04 09:06:39 CST 2023, time=2023-10-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136545, encodeId=a0702136545ef, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传 经验分享：投稿之后第二天就送了外审，一共四个审稿人。做的工作量稍大，偏基础，结合了bulk和单细胞数据分析。回修了三轮。编辑效率很高，很快处理文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230517/c94e696c22d346189f6cad2204d150c3.jpeg, type=image, width=487, height=721)], authenticateStatus=null, createdAvatar=, createdBy=57ae1631459, createdName=翌聲, createdTime=Wed May 17 13:15:10 CST 2023, time=2023-05-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192635, encodeId=c747219263537, content=准备投稿，看了大家评论，着急用文章，是不是不适合投这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/8f96f2c4e958d9381c71fd917902c6e7.jpg, createdBy=77442514173, createdName=职场小白, createdTime=Mon Mar 11 19:15:11 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=587139, encodeId=335e58e1396f, content=请问你从投到送审用了多久啊？我3.11显示editor assigned，今天都21号了，都没有变化，都10天了zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, beContent=zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoiaMS5CKu2YVJn7icDDrYG3ia3605r4AlgvkSuZlOrMic0LzfricZRAxwEMibf25ctcRIqEsdZJaicmnmbA/132, createdBy=72b22205339, createdName=cxw1008, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=)]

2020-03-26 1231e470m09(暂无昵称)

2月28号提交修过的稿，现在还在editor assigned 救救孩子吧

121 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097782, encodeId=5f98209e78283, content=我也来记录一下，2022.10.22投稿，2022.11.1状态变为1 reviewer accepted,目前感觉还挺快，希望一切顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743d5543690, createdName=孤松, createdTime=Tue Nov 01 10:55:10 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089070, encodeId=520620890e08b, content=太慢了 40天了还是Editor appointed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Mon Sep 19 18:52:38 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160854, encodeId=f255216085438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤 经验分享：230808投稿，230929显示1 Reviewer report received ，231003显示Editor appointed 。请问这是倒退了么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaf8384511, createdName=ms1000001061839733, createdTime=Wed Oct 04 09:06:39 CST 2023, time=2023-10-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136545, encodeId=a0702136545ef, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传 经验分享：投稿之后第二天就送了外审，一共四个审稿人。做的工作量稍大，偏基础，结合了bulk和单细胞数据分析。回修了三轮。编辑效率很高，很快处理文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230517/c94e696c22d346189f6cad2204d150c3.jpeg, type=image, width=487, height=721)], authenticateStatus=null, createdAvatar=, createdBy=57ae1631459, createdName=翌聲, createdTime=Wed May 17 13:15:10 CST 2023, time=2023-05-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192635, encodeId=c747219263537, content=准备投稿，看了大家评论，着急用文章，是不是不适合投这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/8f96f2c4e958d9381c71fd917902c6e7.jpg, createdBy=77442514173, createdName=职场小白, createdTime=Mon Mar 11 19:15:11 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=587139, encodeId=335e58e1396f, content=请问你从投到送审用了多久啊？我3.11显示editor assigned，今天都21号了，都没有变化，都10天了zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, beContent=zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoiaMS5CKu2YVJn7icDDrYG3ia3605r4AlgvkSuZlOrMic0LzfricZRAxwEMibf25ctcRIqEsdZJaicmnmbA/132, createdBy=72b22205339, createdName=cxw1008, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=)]

2024-03-11 职场小白来自北京

准备投稿，看了大家评论，着急用文章，是不是不适合投这个期刊

15 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2097782, encodeId=5f98209e78283, content=我也来记录一下，2022.10.22投稿，2022.11.1状态变为1 reviewer accepted,目前感觉还挺快，希望一切顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743d5543690, createdName=孤松, createdTime=Tue Nov 01 10:55:10 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089070, encodeId=520620890e08b, content=太慢了 40天了还是Editor appointed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Mon Sep 19 18:52:38 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160854, encodeId=f255216085438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤 经验分享：230808投稿，230929显示1 Reviewer report received ，231003显示Editor appointed 。请问这是倒退了么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaf8384511, createdName=ms1000001061839733, createdTime=Wed Oct 04 09:06:39 CST 2023, time=2023-10-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2136545, encodeId=a0702136545ef, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传 经验分享：投稿之后第二天就送了外审，一共四个审稿人。做的工作量稍大，偏基础，结合了bulk和单细胞数据分析。回修了三轮。编辑效率很高，很快处理文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230517/c94e696c22d346189f6cad2204d150c3.jpeg, type=image, width=487, height=721)], authenticateStatus=null, createdAvatar=, createdBy=57ae1631459, createdName=翌聲, createdTime=Wed May 17 13:15:10 CST 2023, time=2023-05-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192635, encodeId=c747219263537, content=准备投稿，看了大家评论，着急用文章，是不是不适合投这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/8f96f2c4e958d9381c71fd917902c6e7.jpg, createdBy=77442514173, createdName=职场小白, createdTime=Mon Mar 11 19:15:11 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=587139, encodeId=335e58e1396f, content=请问你从投到送审用了多久啊？我3.11显示editor assigned，今天都21号了，都没有变化，都10天了zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, beContent=zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoiaMS5CKu2YVJn7icDDrYG3ia3605r4AlgvkSuZlOrMic0LzfricZRAxwEMibf25ctcRIqEsdZJaicmnmbA/132, createdBy=72b22205339, createdName=cxw1008, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=)]

2020-03-21 cxw1008

请问你从投到送审用了多久啊？我3.11显示editor assigned，今天都21号了，都没有变化，都10天了zblpd 2020-03-02 16:47:00 发表:
经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久

zblpd 2020-03-02 16:47:00 发表: 经过近7个月的折腾重要接收了，杂志很严谨，还不错，就是时间有些久

112 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务